Search research articles
Contact Us
Filters
Showing results (21-30 of 63) with videos related to
Page
of 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2002
Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie
S Négrier, B Escudier, F Gomez, et al.
Disease Markers
|
December 14, 1999
Four years analysis of cancer genetic clinics activity in France from 1994 to 1997: a survey on 801 patients. French Cooperative Network/Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le Cancer
H Sobol, Y J Bignon, C Bonaiti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia
J Y Blay, F Chauvin, A Le Cesne, et al.
Bone Marrow Transplantation
|
July 1, 1994
Comparison of auto versus allografting as consolidation of primary treatments in advanced neuroblastoma over one year of age at diagnosis: report from the European Group for Bone Marrow Transplantation
R Ladenstein, C Lasset, O Hartmann, et al.
Familial Cancer
|
October 24, 2003
Comparison of physicians' and cancer prone women's attitudes about breast/ovarian prophylactic surgery. Results from two national surveys
F Eisinger, D Stoppa-Lyonnet, C Lasset, et al.
Bone Marrow Transplantation
|
May 1, 1995
Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry
R Ladenstein, C Lasset, R Pinkerton, et al.
British Journal of Cancer
|
June 1, 1995
Is neuroblastoma screening evaluation needed and feasible?
J Estève, L Parker, P Roy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1993
Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow Transplantation
R Ladenstein, C Lasset, O Hartmann, et al.
Bulletin Du Cancer
|
July 1, 1993
[Treatment with cytokines of metastatic kidney cancer: the Lyon experience]
S Négrier, A Mercatello, B Coronel, et al.
British Journal of Cancer
|
November 1, 1993
Patients with metastatic renal carcinoma candidate for immunotherapy with cytokines. Analysis of a single institution study on 181 patients
T Philip, S Negrier, C Lasset, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 63) with videos related to
Sort By:
Page
of 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2002
Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie
S Négrier, B Escudier, F Gomez, et al.
Disease Markers
|
December 14, 1999
Four years analysis of cancer genetic clinics activity in France from 1994 to 1997: a survey on 801 patients. French Cooperative Network/Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le Cancer
H Sobol, Y J Bignon, C Bonaiti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia
J Y Blay, F Chauvin, A Le Cesne, et al.
Bone Marrow Transplantation
|
July 1, 1994
Comparison of auto versus allografting as consolidation of primary treatments in advanced neuroblastoma over one year of age at diagnosis: report from the European Group for Bone Marrow Transplantation
R Ladenstein, C Lasset, O Hartmann, et al.
Familial Cancer
|
October 24, 2003
Comparison of physicians' and cancer prone women's attitudes about breast/ovarian prophylactic surgery. Results from two national surveys
F Eisinger, D Stoppa-Lyonnet, C Lasset, et al.
Bone Marrow Transplantation
|
May 1, 1995
Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry
R Ladenstein, C Lasset, R Pinkerton, et al.
British Journal of Cancer
|
June 1, 1995
Is neuroblastoma screening evaluation needed and feasible?
J Estève, L Parker, P Roy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1993
Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow Transplantation
R Ladenstein, C Lasset, O Hartmann, et al.
Bulletin Du Cancer
|
July 1, 1993
[Treatment with cytokines of metastatic kidney cancer: the Lyon experience]
S Négrier, A Mercatello, B Coronel, et al.
British Journal of Cancer
|
November 1, 1993
Patients with metastatic renal carcinoma candidate for immunotherapy with cytokines. Analysis of a single institution study on 181 patients
T Philip, S Negrier, C Lasset, et al.
Page
of 7